Smernice za zdravljenje bolnikov z rakom požiralnika in ezofagogastričnega stika (EGS)

Izpis gradiva
A+ | A- | SLO | ENG

Naslov:	Smernice za zdravljenje bolnikov z rakom požiralnika in ezofagogastričnega stika (EGS)
Avtorji:	Anderluh, Franc (Avtor) But Hadžić, Jasna (Avtor) Crnjac, Anton (Avtor) Gačevski, Goran (Avtor) Hlebanja, Zvezdana (Avtor) Jeromen, Ana (Avtor) Oblak, Irena (Avtor) Ocvirk, Janja (Avtor) Reberšek, Martina (Avtor) Sok, Mihael (Avtor) Srpčič, Matevž (Avtor) Šečerov Ermenc, Ajra (Avtor) Štabuc, Borut (Avtor) Velenik, Vaneja (Avtor) Volk, Neva (Avtor)
Jezik:	Slovenski jezik
Tipologija:	1.04 - Strokovni članek
Organizacija:	OI - Onkološki inštitut Ljubljana
Ključne besede:	rak požiralnika, rak ezofagogastričnega stika, zdravljenje, smernice
Leto izida:	2016
UDK:	616.3
ISSN pri članku:	1408-1741
OceCobissID:	65324032
COBISS_ID:	2663035
Število ogledov:	2652
Število prenosov:	559
Datoteke:	PDF - Predstavitvena datoteka, prenos (531,57 KB)

Nadgradivo:	Onkologija Onkološki inštitut

Metapodatki:
Avtorske pravice:	by Authors
:

Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Licenca:	CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna

Povezava:	http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:	To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:	03.01.2018

Jezik:	Angleški jezik
Naslov:	Guidelines for Treating Patients with Cancer of the Esophagus and Esophagogastric Juncture (EGS)
Povzetek:	Oesophageal cancer is a relatively rate tumor with high mortality. It is most frequent in men in their sixties or seventies. In the past years, a constant increase in the incidence of adenocarcinoma of the distal esophagus and esophagogastric juncture (EGS) has been observed in the West. This can probably be attributed changing lifestyle with increases obesity incidence and gastroesophageal reflux disease. The latest, 7th review of the TNM Classification classifies both – cancer of the esophagus and cancer of the esophagogastric juncture – as oesophageal cancer. In a select group of patients this disease is curable, however the treatment is long, usually combined and with high morbidity that can significantly impact the patient’s quality of life. Due to the specific anatomy, cancer of the esophagus and cancer of the esophagogastric juncture develop metastasis early, and the prognosis is worse compared to other gastrointestinal cancers.

niGradiv

Nazaj